☆ 4.6 Editorial Material

Immune thrombocytopenia in the elderly: immunosenescent and clinical diversity comment

BRITISH JOURNAL OF HAEMATOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry

Aurelien Sokal et al.

Summary: Data on the presentation and management of primary immune thrombocytopenia (ITP) in very elderly patients (VEPs; aged >= 80 years) are lacking. This study aimed to describe ITP in this subgroup and found that VEPs have a higher likelihood of severe bleeding, with female sex and a platelet count of <20 x 10(9)/l being associated with bleeding. Exposure to anticoagulants is strongly associated with severe bleeding in VEPs.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Review Immunology

The Complex Role of Regulatory T Cells in Immunity and Aging

Lourdes Rocamora-Reverte et al.

Summary: The immune system is a tightly regulated network, where regulatory T cells play an important role in maintaining immune homeostasis. Different types of T cells have regulatory functions in modulating immune responses, and the aging process can affect the composition of immune cells.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Hematology

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Francesca Palandri et al.

Summary: Thrombopoietin receptor agonists (TRAs) demonstrate good efficacy in older patients aged 60 years and above with ITP, with no fatal hemorrhages and sustained responses off-treatment observed in a significant portion of patients. Caution is advised in patients with a history of thrombosis, and a careful risk/benefit balance should be considered when using TRAs.

BLOOD (2021)

添加到收藏夹

Article Hematology

Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years

Francesca Palandri et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Medicine, General & Internal

Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim

Christian Fynbo Christiansen et al.

ECLINICALMEDICINE (2019)

添加到收藏夹

Article Hematology

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert et al.

BLOOD ADVANCES (2019)

添加到收藏夹

Review Hematology

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan et al.

BLOOD ADVANCES (2019)

添加到收藏夹

Article Hematology

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia

Julie Waisbren et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

添加到收藏夹

Article Hematology

Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France

Guillaume Moulis et al.

BLOOD (2014)

添加到收藏夹

Article Hematology

Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China

Hu Zhou et al.

ANNALS OF HEMATOLOGY (2013)

添加到收藏夹

Article Hematology

Prevalence of primary immune thrombocytopenia in Oklahoma

Deirdra R. Terrell et al.

AMERICAN JOURNAL OF HEMATOLOGY (2012)

添加到收藏夹

Article Hematology

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

Weili Bao et al.

BLOOD (2010)

添加到收藏夹

Review Hematology

The ITP syndrome: pathogenic and clinical diversity

Douglas B. Cines et al.

BLOOD (2009)

添加到收藏夹

Article Hematology

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

W. Marieke Schoonen et al.

BRITISH JOURNAL OF HAEMATOLOGY (2009)

添加到收藏夹

Article Hematology

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients

Detlef Haase et al.

BLOOD (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.